Simon Hsu
Overview
Explore the profile of Simon Hsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Best C, Li X, Rotter J, Prince D, Hsu S, Hoofnagle A, et al.
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39815761
Context: The response to treatment with vitamin D varies between patients. Objective: To identify genetic variants associated with the biochemical response to vitamin D3 supplementation. Design: Randomized placebo-controlled trial conducted...
2.
Hsu S, Bansal N, Denburg M, Ginsberg C, Hoofnagle A, Isakova T, et al.
J Bone Miner Res
. 2024 Mar;
39(4):433-442.
PMID: 38477777
Fracture risk is high in chronic kidney disease (CKD) and underlying pathophysiology and risk factors may differ from the general population. In a cohort study of 3939 participants in the...
3.
Hsu S, Zelnick L, Buring J, Chou S, Cook N, DAgostino D, et al.
Clin J Am Soc Nephrol
. 2024 Jan;
19(5):638-640.
PMID: 38265769
No abstract available.
4.
Ginsberg C, Blackwell T, Cheng J, Potok O, Cauley J, Ensrud K, et al.
J Clin Endocrinol Metab
. 2023 Oct;
109(2):e513-e521.
PMID: 37804103
Context: Serum 25-hydroxyvitamin D (25(OH)D) is the current marker of vitamin D adequacy, but its relationship with bone health has been inconsistent. The ratio of 24,25-dihydroxyvitamin D3 to 25(OH)D3 (vitamin...
5.
Hsu S, Vervloet M, de Boer I
Am J Kidney Dis
. 2023 Sep;
82(5):512-514.
PMID: 37715768
No abstract available.
6.
Vervloet M, Hsu S, de Boer I
Kidney Int
. 2023 Aug;
104(4):698-706.
PMID: 37541585
Vitamin D supplements have long been advocated for people with chronic kidney disease based on data from observational studies among the general population and people with chronic kidney disease. These...
7.
Hsu S, Zelnick L, Bansal N, Brown J, Denburg M, Feldman H, et al.
J Am Heart Assoc
. 2023 Jul;
12(14):e028561.
PMID: 37421259
Background The ratio of 24,25-dihydroxyvitamin D/25-hydroxyvitamin D (vitamin D metabolite ratio [VDMR]) may reflect functional vitamin D activity. We examined associations of the VDMR, 25-hydroxyvitamin D (25[OH]D), and 1,25-dihydroxyvitamin D...
8.
Bergagnini-Kolev M, Hsu S, Aitken M, Goss C, Hoofnagle A, Zelnick L, et al.
J Steroid Biochem Mol Biol
. 2023 May;
232:106332.
PMID: 37217104
Patients with cystic fibrosis (CF) commonly have lower circulating concentrations of 25-hydroxyvitamin D (25(OH)D) than healthy populations. We comprehensively compared measures of vitamin D metabolism among individuals with CF and...
9.
Best C, Hsu S
Curr Opin Endocrinol Diabetes Obes
. 2023 May;
30(4):184-191.
PMID: 37132326
Purpose Of Review: Very low carbohydrate ketogenic diet (KD) therapy has been associated with skeletal demineralization in children with drug-resistant epilepsy, but the cause of this association is unclear. Recently,...
10.
Hsu S, Bi J, de Boer I
Environ Health Perspect
. 2023 Apr;
131(4):41302.
PMID: 37036791
No abstract available.